0001104659-24-084069.txt : 20240730 0001104659-24-084069.hdr.sgml : 20240730 20240730194938 ACCESSION NUMBER: 0001104659-24-084069 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240726 FILED AS OF DATE: 20240730 DATE AS OF CHANGE: 20240730 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MALIK NAVID CENTRAL INDEX KEY: 0001629113 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35737 FILM NUMBER: 241159485 MAIL ADDRESS: STREET 1: 1 CHOLMELEY PARK STREET 2: HIGHGATE CITY: LONDON STATE: X0 ZIP: N6 5ET ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NORTHWEST BIOTHERAPEUTICS INC CENTRAL INDEX KEY: 0001072379 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 943306718 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4800 MONTGOMERY LANE STREET 2: SUITE 800 CITY: BETHESDA STATE: MD ZIP: 20814 BUSINESS PHONE: (240) 497-9024 MAIL ADDRESS: STREET 1: 4800 MONTGOMERY LANE STREET 2: SUITE 800 CITY: BETHESDA STATE: MD ZIP: 20814 4 1 tm2420472-1_4seq1.xml OWNERSHIP DOCUMENT X0508 4 2024-07-26 0 0001072379 NORTHWEST BIOTHERAPEUTICS INC NWBO 0001629113 MALIK NAVID C/O NORTHWEST BIOTHERAPEUTICS, INC. 48 MONTGOMERY LANE, SUITE 800 BETHESDA MD 20814 1 0 0 0 0 Stock Option 0.23 2024-07-26 4 S 0 657895 0.38 D 2018-05-28 2028-05-28 Common Stock 657895 23339393 D *Mr. Malik sold 657,895 common stock options to Mr. Jerry Jasinowski, former director of Northwest Biotherapeutics, Inc. /s/ Navid Malik 2024-07-30